<DOC>
	<DOCNO>NCT00460473</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety perioperative use dexmedetomidine prevention postoperative delirium subject undergo surgery fracture hip general anesthesia .</brief_summary>
	<brief_title>A Research Study Evaluate Effectiveness Dexmedetomidine Preventing Delirium After Hip Fracture Repair Surgery</brief_title>
	<detailed_description>Postoperative delirium acute decline cognition attention usually transient delirium persist impact cognitive function , morbidity morality . There drug currently approve prevent onset delirium dexmedetomidine potential meet unmet medical need . Hip fracture , unfortunately frequent occurrence elderly population elderly prone develop delirium surgery . Dexmedetomidine currently approve use 24 hour patient ventilator ICU . Study participation last within 72 hour surgery 3 day surgery , continue throughout surgery 2 hour surgery . Delirium assess prior surgery 72 hour surgery . This assessment consist question determine memory thought process . At discharge patient 's resource utilization evaluate thirty day surgery question ask regard quality life .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Adult ( ≥18 year old ) male female undergo surgery fracture hip general anesthesia within 72 hour admission hospital . 2 . If female , subject nonlactating either : 1 . Not childbearing potential , defined postmenopausal least 1 year surgically sterile due bilateral tubal ligation , bilateral oophorectomy hysterectomy . 2 . Of childbearing potential pregnant time baseline practice one follow method birth control : oral parenteral contraceptive , doublebarrier method , vasectomized partner , abstinence sexual intercourse . 3 . Subject American Society Anesthesiologists Physical Status I , II , III , IV . 4 . Subject ( subject 's legally authorize representative ) voluntarily sign date informed consent document approve Institutional Review Board ( IRB ) . 1 . Cognitive function level Mini Mental State Exam ( MMSE ) ≤20 . 2 . Subject positive CAMICU result delirium Screening Baseline . 3 . Subject require chronic antipsychotic therapy . 4 . Subject anticipated require additional surgical procedure 72 hour Screening Period 3 day Followup Period . 5 . Subject anticipated require repair pelvic fracture ( eg , acetabulum ) . 6 . Subject participate trial experimental drug experimental implantable device within 30 day prior study drug administration , ever enrol study . 7 . Subject know liver failure . 8 . Subject anticipated potential increase intracranial pressure uncontrolled seizure disorder know psychiatric illness could confound normal response study assessment . 9 . Subject receive treatment α2agonist antagonist ( within 14 day study entry ) . 10 . Subject opiate , benzodiazepine , DEX α2agonists contraindicate . 11 . Subject , per investigator 's judgment , know suspected physical psychological dependence abuse drug , alcohol . 12 . Subject acute unstable angina , acute myocardial infarction , HR &lt; 50 bpm , SBP &lt; 90 mmHg , third degree heart block unless subject pacemaker . 13 . Subject condition factor , Investigator 's opinion , might increase risk subject . 14 . Subject expect live 60 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Mental Health</keyword>
	<keyword>Neurological Disease</keyword>
	<keyword>Hip Injuries Disorders</keyword>
</DOC>